GAD65 autoantibody titres at diagnosis in Latent Autoimmune Diabetes in Adults (LADA) differ from Type 1 diabetes (T1D) and together with epitope specificity predict insulin requirement
Main Authors: | Desai, M, Williams, A, Horton, V, Bingley, P, Levy, J, Cull, C, Holman, R, Bonifacio, E, Christie, MR, Clark, A |
---|---|
Format: | Conference item |
Published: |
2004
|
Similar Items
-
GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.
by: Desai, M, et al.
Published: (2007) -
Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
by: Davison, L, et al.
Published: (2008) -
Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
by: Clark, A, et al.
Published: (2005) -
Genetic and immunological characterisation of patients with latent autoimmune diabetes in adults (LADA)
by: Desai, M, et al.
Published: (2005) -
Susceptibility effects of variation at the IDDM2 (Insulin-gene) locus in latent autoimmune diabetes in adults (LADA).
by: Desai, M, et al.
Published: (2003)